Souza, Crystal

Souza, Crystal was paid $233K by Medicaid between Jan 2018 and Dec 2024, across 17 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 74% of everything it billed.

33Billing provider infoSOUZA, CRYSTAL
WOONSOCKET, RI 02895

33aNPI1467826693assigned 11/27/2015

33bProvider typeFamily Nurse Practitioner

28Total paid$233K

24GClaims5,457

24DCodes billed17

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Family Nurse Practitioner providers in Rhode Island

Rank by total paid#24 of 266

Median peer was paid$31K

This provider vs. median7.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,098	$45K
2019	614	$26K
2020	834	$37K
2021	1,374	$55K
2022	877	$38K
2023	361	$18K
2024incomplete	299	$16K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	74%	3,775	3,577	$173K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	11%	317	274	$25K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	3.8%	280	264	$9K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	1.7%	64	63	$4K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	1.7%	402	390	$4K
87428		1.7%	69	69	$4K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	1.7%	264	255	$4K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.1%	19	19	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	1.0%	37	37	$2K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	13	13	$997.85
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	12	12	$928.50
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	12	12	$928.50

5 more codes

87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	19	$658.33
87086	Culture, bacterial; quantitative colony count, urine	<1%	42	$621.84
83036	Hemoglobin; glycosylated (A1C)	<1%	27	$617.34
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	64	$510.40
81002		<1%	41	$90.79

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.